Prescription Drugs

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, this week took to the Senate Floor to highlight the Senate Finance Committee’s new report that found Pfizer, which generated $20 billion in U.S. sales of prescription drugs in 2019,…

Sen. Peter Welch, D-Vermont, is co-sponsoring legislation that would allow Americans to "safely" import prescription drugs from Canada, where costs are a fraction of what they are in the United States, creating more competition in the pharmaceutical market. "Skyrocketing drug prices are hammering patients in Vermont…

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.) this week joined Senators Amy Klobuchar (D-Minn.) and Chuck Grassley (R-Iowa) to introduce the Safe and Affordable Drugs from Canada Act, bipartisan legislation which would allow Americans to safely import prescription drugs from Canada, lowering costs, increasing…

Proposed rule is in alignment with the Senators’ bipartisan bill to hold Big Pharma accountable for abusing the patent system WASHINGTON, D.C. – Senators Peter Welch (D-Vt.), Mike Braun (R-Ind.),and Amy Klobuchar (D-Minn.) sent a letter to Kathi Videl, Director of the U.S. Patent and…

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.) today introduced the bicameral 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support (PATIENTS) Act, legislation that would protect the 340B drug pricing program and ensure patients—especially those in lower income and rural communities—can continue…